- Date 31 Oct 2017
- Sectors Life Sciences
“Demand for custom DNA is growing exponentially – with applications in manufacturing, medicine, and even information storage”, said George Church. “Nuclera represents fresh approaches, which will improve cost and quality very significantly.”
“George’s experience in helping build successful biotech companies, and his visions for the future of synthetic biology will be invaluable for a young and growing company like Nuclera”, said Jiahao Huang, co-founder of Nuclera. “We are privileged to have him be the founding member of our Scientific Advisory Board, and looking forward to working with George to explore novel applications for our enzyme-based DNA synthesis platform.”
Church is Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT). He also leads Synthetic Biology at the Wyss Institute. He developed the first direct genomic sequencing method, and helped initiate the Human Genome Project in 1984, the Personal Genome Project in 2005, and GP-Write in 2016. He has also helped founded more than 14 biotech companies, such as Editas, Gen9bio, Veritas Genetics and eGenesis.